ARGENTEM CREEK PARTNERS

RIASEC RegisteredEst. 2015
Total AUM
$628M
Discretionary
$551M
88% of AUM
Avg account
$126M
Accounts
5
Employees
12
Advisory reps
3

Firm details

Headquarters
New York, New York
CRD number
282070
Registered since
December 4, 2015
Fee structure
Percentage of AUM, Fixed Fees, Performance Based Fees
Client types
  • Pooled Investment Vehicles100%
Services
Portfolio Management for Pooled Investment Vehicles

Firm profile

FINTRX

Overview

Argentem Creek Partners is organized as a limited partnership and is classified as a private equity fund that serves institutional clients. Formed and SEC-registered in 2015, the firm operates as an adviser and sponsor of pooled investment vehicles and is registered with business activities that include CPO/CTA functions and portfolio management for pooled vehicles. Its revenue model combines AUM-based fees with fixed charges and performance-based fees. Filings identify the firm as an active ESG investor, and its corporate structure indicates the firm acts in GP and managing-member roles for sponsored vehicles.

Assets & Accounts

Investments & Alternatives

Location & Offices

Investment profile

FINTRX

Traditional investments used

Alternative investments used

Active ESG investor

Technology & operations

FINTRX

CRM & tech providers

TAMPs used

Clients

FINTRX

Client base

Client personas

Owners & executives

3 of 3
  • UZI ROSHA

    Chief Compliance OfficerCRD 4801414

  • DANIEL CHAPMAN

    Founder, CEO and Co-CIOCRD 2314185

  • MAARTEN TERLOUW

    President & Co-Chief Investment OfficerCRD 6851003

Wealth teams

FINTRX

Newly hired reps

FINTRX

Recent M&A activity

FINTRX

Recent filings

FINTRX

Awards

FINTRX

Location

Primary office

New York, NY

NEW YORK

Location

New York, NY

Headquartered in New York, NY, anchoring the New York-Newark, NY-NJ-CT-PA metro in the Northeast.

Metro area
New York-Newark, NY-NJ-CT-PA
Region
Northeast
County
NEW YORK
Address
156 W 56th St
Time zone
ET (UTC-5)
Office locations

Similar firms

Source: FINTRX private wealth data intelligence

Intelligence for Private Wealth